U.S. flag

An official website of the United States government

NM_017849.4(TMEM127):c.532dup (p.Tyr178fs) AND Hereditary pheochromocytoma-paraganglioma

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Nov 5, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001215668.6

Allele description [Variation Report for NM_017849.4(TMEM127):c.532dup (p.Tyr178fs)]

NM_017849.4(TMEM127):c.532dup (p.Tyr178fs)

Gene:
TMEM127:transmembrane protein 127 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
2q11.2
Genomic location:
Preferred name:
NM_017849.4(TMEM127):c.532dup (p.Tyr178fs)
HGVS:
  • NC_000002.12:g.96253993dup
  • NG_027695.1:g.17021dup
  • NM_001193304.3:c.532dup
  • NM_017849.4:c.532dupMANE SELECT
  • NP_001180233.1:p.Tyr178fs
  • NP_060319.1:p.Tyr178fs
  • NP_060319.1:p.Tyr178fs
  • LRG_528t1:c.532dup
  • LRG_528:g.17021dup
  • LRG_528p1:p.Tyr178fs
  • NC_000002.11:g.96919730_96919731insA
  • NC_000002.11:g.96919731dup
  • NM_017849.3:c.532dup
  • NM_017849.3:c.532dupT
Protein change:
Y178fs
Links:
dbSNP: rs1553436874
NCBI 1000 Genomes Browser:
rs1553436874
Molecular consequence:
  • NM_001193304.3:c.532dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_017849.4:c.532dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Hereditary pheochromocytoma-paraganglioma
Synonyms:
Hereditary Paraganglioma-Pheochromocytoma Syndromes; Hereditary Paragangliomas and Pheochromocytomas
Identifiers:
MONDO: MONDO:0017366; MedGen: C1708353

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001387423Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Nov 5, 2021)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular and phenotypic evaluation of a novel germline TMEM127 mutation with an uncommon clinical presentation.

Deng Y, Flores SK, Cheng Z, Qin Y, Schwartz RC, Malchoff C, Dahia PLM.

Endocr Relat Cancer. 2017 Nov;24(11):L79-L82. doi: 10.1530/ERC-17-0359. Epub 2017 Aug 30. No abstract available. Erratum in: Endocr Relat Cancer. 2018 Sep;25(9):X3.

PubMed [citation]
PMID:
28855235
PMCID:
PMC5741081

Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.

Bausch B, Schiavi F, Ni Y, Welander J, Patocs A, Ngeow J, Wellner U, Malinoc A, Taschin E, Barbon G, Lanza V, Söderkvist P, Stenman A, Larsson C, Svahn F, Chen JL, Marquard J, Fraenkel M, Walter MA, Peczkowska M, Prejbisz A, Jarzab B, et al.

JAMA Oncol. 2017 Sep 1;3(9):1204-1212. doi: 10.1001/jamaoncol.2017.0223.

PubMed [citation]
PMID:
28384794
PMCID:
PMC5824290
See all PubMed Citations (3)

Details of each submission

From Invitae, SCV001387423.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change creates a premature translational stop signal (p.Tyr178Leufs*48) in the TMEM127 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 61 amino acid(s) of the TMEM127 protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of paraganglioma-pheochromocytoma syndrome (PMID: 28384794, 28855235; Invitae). ClinVar contains an entry for this variant (Variation ID: 421874). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects TMEM127 function (PMID: 28855235). This variant disrupts the C-terminus of the TMEM127 protein. Other variant(s) that disrupt this region (p.Ala186Argfs*44) have been observed in individuals with TMEM127-related conditions (PMID: 28384794). This suggests that this may be a clinically significant region of the protein. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024